<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03945422</url>
  </required_header>
  <id_info>
    <org_study_id>DO608522A</org_study_id>
    <nct_id>NCT03945422</nct_id>
  </id_info>
  <brief_title>The Use of RF in Premature Jowl and Neck Laxity Following Facialplasty</brief_title>
  <official_title>The Use of Radio Frequency in Premature Jowl and Neck Laxity Following Facialplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>InMode MD Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>InMode MD Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study is to evaluate the efficacy of treatment Radio Frequency in premature jowl and neck&#xD;
      laxity following facialplasty&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date type="Actual">April 15, 2019</start_date>
  <completion_date type="Anticipated">April 3, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 3, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Subjects will receive the treatment and outcome will be followed</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in skin appearance</measure>
    <time_frame>3 months, 6 month, 9 months</time_frame>
    <description>Photos from all time points (baseline and follow-up visits) will be evaluated by the treating physician and 2 independent evaluators.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Investigator assessment of the skin appearance</measure>
    <time_frame>3 Month, 6 Months, 9 Months</time_frame>
    <description>Investigator assessment of the skin appearance improvement comparing pre and post treatment using 0 - 4 -points Likert scale: 4 = Significantly marked improvement; 3 = Marked improvement; 2 = Moderate improvement; 1 = Slight improvement ; 0 = No difference.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Optional: 3D Photographic analysis</measure>
    <time_frame>3 months, 6 month, 9 months</time_frame>
    <description>3D Photographic analysis will be conducted using QuantifiCare System</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate changes in skin appearance comparing photographs using Mechanical Turk (MTurk). The pictures will be sent through the system and evaluated by crowd workers.</measure>
    <time_frame>3 Months, 6 Months</time_frame>
    <description>The pictures will be sent through the system and evaluated by crowd workers.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Premature Jowl and Neck Laxity Following Facialplasty</condition>
  <arm_group>
    <arm_group_label>Treatment Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject will receive AccuTite/FaceTite and Morpheus8 treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AccuTite/FaceTite</intervention_name>
    <description>Radiofrequency-assisted lipolysis (RFAL) Morpheus8: Fractional RF</description>
    <arm_group_label>Treatment Arm</arm_group_label>
    <other_name>Morpheus8</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult females and males between the ages of 40-80 inclusive, having premature jowl&#xD;
             and/or neck laxity one to fifteen years following facialplasty, seeking skin&#xD;
             tightening treatments.&#xD;
&#xD;
          -  Lack lipodystrophy in the jowl or neck area or at least not amenable to liposuction&#xD;
             improvement (not a candidate for liposuction).&#xD;
&#xD;
          -  Lack of previous Face Lift complications (no nerve injury or hematoma history).&#xD;
&#xD;
          -  The patients should understand the information provided about the investigative nature&#xD;
             of the treatment, possible benefits and side effects, and sign the Informed Consent&#xD;
             Form, (including thepermission to use photography).&#xD;
&#xD;
          -  The patients should be willing to comply with the study procedure and schedule,&#xD;
             including the follow up visit, and will refrain from using any other aesthetic&#xD;
             treatment methods for the last 6 months and during the entire study period.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pacemaker or internal defibrillator, or any other active electrical implant anywhere&#xD;
             in the body.&#xD;
&#xD;
          -  The Handpiece should be used at least 1cm away from cochlear implants in the ear.&#xD;
&#xD;
          -  Superficial permanent implant in the treated area such as metal plates and screws,&#xD;
             metal piercing, silicone implants or an injected chemical substance.&#xD;
&#xD;
          -  Current or history of skin cancer (remission of 5 years), or current condition of any&#xD;
             other type of cancer, or pre-malignant moles.&#xD;
&#xD;
          -  Severe concurrent conditions, such as cardiac disorders, epilepsy, uncontrolled&#xD;
             hypertension, and liver or kidney diseases.&#xD;
&#xD;
          -  Pregnancy and nursing.&#xD;
&#xD;
          -  History of bleeding coagulopathies or use of anticoagulants&#xD;
&#xD;
          -  Impaired immune system due to immunosuppressive diseases such as AIDS and HIV or use&#xD;
             of immunosuppressive medications.&#xD;
&#xD;
          -  Poorly controlled endocrine disorders, such as diabetes or thyroid dysfunction and&#xD;
             hormonalvirilization.&#xD;
&#xD;
          -  Any active condition in the treatment area, such as sores, psoriasis, eczema, and&#xD;
             rash.&#xD;
&#xD;
          -  History of skin disorders, keloids, abnormal wound healing, as well as very dry and&#xD;
             fragile skin.&#xD;
&#xD;
          -  Use of Isotretinoin (AccutaneÂ®) within 6 months prior to treatment.&#xD;
&#xD;
          -  Any surgery or treatment such as laser or chemicals in treated area within 3-6 months&#xD;
             prior to treatment or before complete healing.&#xD;
&#xD;
          -  Allergies, in particular to anesthesia.&#xD;
&#xD;
          -  Mental disorders such as Body Dysmorphic Disorder (BDD).&#xD;
&#xD;
          -  As per the practitioner's discretion, refrain from treating any condition that might&#xD;
             make it unsafe for the patient.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Chicago Center for Facial Plastics</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>May 7, 2019</study_first_submitted>
  <study_first_submitted_qc>May 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 10, 2019</study_first_posted>
  <last_update_submitted>September 23, 2019</last_update_submitted>
  <last_update_submitted_qc>September 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

